Tenders

Finished Medicinal Product with the Active Substance Combination Formoterol and Beclometasone (Atc: R03ak08)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Implementation of a Dynamic Procurement System for the Supply of Cleaning Products and Supplies

Finished Medicinal Product with the Active Substance Rituximab - in the Form of Infusion Solution Concentrate (Atc: L01fa01)

Finished Medicinal Product with the Active Ingredient Combination Brinzolamide and Timolol (Atc: S01ed67)

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Ginkgo Biloba Leaf Dry Extract, Atc N06dp01 for the Period 01/01/2023 - 12/31/2024

Acquisition of Secure Marriage Declaration Forms

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Sevelamer Hydrochloride, Atc V03ae02 for the Period January 1St, 2023 - December 31St, 2024

Dps Qualification for Pulmonary Function and Sleep Testing Equipment

Skills Bootcamps - Dynamic Purchasing System